|
|
|
|
|
by crispycas12
481 days ago
|
|
I believe he got just got either Ipilimumab and Nivolumab as a combo therapy or Pembrolizumab. He's a researcher who focuses on neo-adjuvant (use therapy before resection) therapy in melanomas. It was a good gamble to try the same paradigm in Glioblastomas |
|
Ipi/nivo/relatlimab and then a peptide vaccine that they haven't written up yet.